Institute of Respiratory Disease, Department of Medical and Occupational Sciences, University of Foggia, Foggia, Italy.
Rejuvenation Res. 2012 Jun;15(3):265-73. doi: 10.1089/rej.2011.1260. Epub 2012 May 2.
The exact diagnosis of malignant pleural effusions (PE) is difficult and often requires combined procedures, because the cytological examination of pleural fluid does not detect tumoral cells in 40% of malignant effusion cases. The aim of this study was to analyze microsatellite alterations (MA) in malignant PE and to determine their diagnostic value as an additional test to cytological examination. The increase in cell-free DNA levels was also evaluated as a signal of probable malignancy.
A total of 84 patients with PE were enrolled and underwent PE and whole blood and exhaled breath condensate analyses. Free DNA was measured by spectrophotometer analyses. DNA was extracted from all samples and analyzed for MA, using the microsatellite markers at chromosomes 3p, 12p, 5q, and 17p.
The microsatellite analysis of PE exhibited a higher percentage of alterations in malignant PE than in benign PE. In addition to this, cell-free DNA in PE was seen to be significantly more elevated in malignant than in benign PE. The sensitivity of the sole cytology increased considerably when patients showed at least one MA or DNA>4 ng/μL in the PE.
In conclusion, it was seen that the combination of the cytological examination with microsatellite analyses and cell-free DNA in pleural fluid could increase the sensitivity of the diagnosis in patients with PE who have a suspected malignancy, obviating the need for other invasive diagnostic procedures.
恶性胸腔积液(PE)的准确诊断较为困难,通常需要联合多种程序,因为胸腔积液的细胞学检查无法在 40%的恶性积液病例中检测到肿瘤细胞。本研究旨在分析恶性 PE 中的微卫星改变(MA),并确定其作为细胞学检查的附加检查的诊断价值。还评估了细胞游离 DNA 水平的升高作为恶性肿瘤的可能信号。
共纳入 84 例胸腔积液患者,进行胸腔积液和全血及呼出气冷凝液分析。分光光度计分析测量游离 DNA。从所有样本中提取 DNA,并用微卫星标记物 3p、12p、5q 和 17p 分析 MA。
PE 的微卫星分析显示恶性 PE 的改变百分比高于良性 PE。此外,恶性 PE 中的细胞游离 DNA 明显高于良性 PE。当 PE 中至少有一个 MA 或 DNA>4ng/μL 时,单独细胞学检查的敏感性显著提高。
总之,胸腔积液的细胞学检查联合微卫星分析和细胞游离 DNA 可以提高疑似恶性胸腔积液患者的诊断敏感性,避免其他侵入性诊断程序。